통합 검색

통합 검색

Jueng Soo You Pubulication

Google scholar Link

2026

Hells protects mitochondrial integrity via Nr2f2 suppression during osteoclast differentiation

  MJ Kim, SK Choi, B Yu, M Kim, UY Choi, S Hwang, WS Choi, JS You 

  Cell Communication and Signaling [8.9 → 11.6] Link

USP21-mediated SMARCB1 stabilization under hypoxia may influence tumor progression and immune response in HCC

  M Kim, MJ Kim, SK Choi, B Yu, UY Choi, S Hwang, WS Choi, JS You 

  Biochemical and Biophysical Research Communications [2.2 → 2.5] Link

2025

Roles of transposable elements and DNA methylation in the formation of CpG

islands and CpG-depleted regulatory elements

  JS You, S Pierce, G Liang, PA Jones 

  Proceedings of the National Academy of Sciences [9.1 → 9.5] Link

HELLS controls mitochondrial dynamics and genome stability in liver cancer

by collusion with MIEF1

  SK Choi, J Park, SY Ha, MJ Kim, SI Ahn, J Kim, W Sun, YM Park, SW Nam, JW Han, K Kang, JS You

  Cell Death & Disease [9.6 → 12.2] Link

αKG-induced oxidative stress and mTOR inhibition as a therapeutic strategy

for liver cancer

  SK Choi, MJ Kim, JS You

  Medical Oncology [3.5] Link

2024
Mdivi-1: Effective but complex mitochondrial fission inhibitor
  SI Ahn, SK Choi, MJ Kim, J Wie, JS You
  Biochemical and Biophysical Research Communications [2.2 → 2.5] Link
2023
Epigenetic landscape analysis reveals the significance of early reduced
chromatin accessibility in osteoclastogenesis
  S Lee, MJ Kim, SI Ahn, SK Choi, KY Min, WS Choi, JS You
  Bone [2.6] Link
2021

Hexosamine biosynthetic pathway-derived O-GlcNAcylation is critical for

RANKL-mediated osteoclast differentiation

  MJ Kim, HS Kim, S Lee, KY Min, WS Choi, JS You

  International journal of molecular sciences [4.9] Link

Glutamine metabolite α-ketoglutarate acts as an epigenetic co-factor to

interfere with osteoclast differentiation

  S Lee, HS Kim, MJ Kim, KY Min, WS Choi, JS You

  Bone [2.6] Link

Nucleoporin 210 serves a key scaffold for SMARCB1 in liver cancer

  SH Hong, KH Son, SY Ha, TI Wee, SK Choi, JE Won, HD Han, Y Ro, YM Park, JW Eun, SW Nam, JW H    an, K Kang, JS You

  Cancer Research [16.6] Link

2020

SMARCB1 acts as a quiescent gatekeeper for cell cycle and immune response

in human cells

  SK Choi, MJ Kim, JS You

  International Journal of Molecular Sciences [4.9] Link

2019

SOX9 is controlled by the BRD4 inhibitor JQ1 via multiple regulation

mechanisms

  SH Hong, JS You

  Biochemical and Biophysical Research Communications [2.2] Link

2018

Oncogenic IL7R is downregulated by histone deacetylase inhibitor in

esophageal squamous cell carcinoma via modulation of acetylated FOXO1

  MJ Kim, SK Choi, SH Hong, JW Eun, SW Nam, JW Han, JS You

  International journal of oncology [4.9] Link

2017

Epigenetic landscape change analysis during human EMT sheds light on

a key EMT mediator TRIM29

  SK Choi, K Pandiyan, JW Eun, X Yang, SH Hong, SW Nam, PA Jones, G Liang, JS You

  Oncotarget [4.9] Link

2016

JQ1, an inhibitor of the epigenetic reader BRD4, suppresses the bidirectional

MYC-AP4 axis via multiple mechanisms

  SK Choi, SH Hong, HS Kim, CY Shin, SW Nam, WS Choi, JW Han, JS You

  Oncology reports [3.9] Link

2015

The epigenetic reader BRD2 as a specific modulator of PAI-1 expression in

lipopolysaccharide-stimulated mouse primary astrocytes

  CS Choi, SH Hong, S Sim, KS Cho, JW Kim, SM Yang, SJ Jeon, JS You, CY Shin

  Neurochemical research [3.8] Link